Ongoing Interventional Clinical Trial Study Drugs
SAM.GOV Due: May 20, 2025 at 04:30 PM UTC
In-Active Presolicitation Source Url

Summary

The opportunity titled 'Ongoing Interventional Clinical Trial Study Drugs' is a presolicitation notice issued by the National Institutes of Health (NIH) for contractors interested in participating in a clinical trial involving study drugs. This project is aimed at conducting interventional clinical trials, which typically require expertise in clinical research, regulatory compliance, and the management of pharmaceutical products. Businesses that specialize in clinical trial management, pharmaceutical development, or have experience in conducting interventional studies are encouraged to bid on this opportunity. The work will take place in Bethesda, Maryland, and is expected to involve collaboration with NIH researchers and adherence to strict clinical trial protocols.
Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
339112
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
Lynda Cole [email protected] 3014027220 primary